Genus PLC
06 August 2007
For Immediate Release 6 August 2007
Genus Plc
Genus, the leading multi species global genetics company makes the following
statement in relation to the case of foot and mouth disease confirmed in GB last
Friday evening.
There is no measurable impact upon our business.
The ravaging 2001 outbreak had no adverse impact on the business. Since that
time Genus has developed both geographically and in species. Currently, only 14%
of company turnover is in GB animal related business.
All of Genus' GB breeding stock facilities are located far from the source of
the outbreak. Nevertheless, we have further enhanced our already high
bio-security procedures.
The Board will keep the situation under constant review and will make a further
announcement if the situation changes from that described above
For further information, please contact:
Genus Plc Tel: +44 (0)1256 345 971
Martin Boden, Finance Director
Buchanan Communications Tel: +44 (0)20 7466 5000
Charles Ryland / Suzanne Brocks
Bridgewell Securities Ltd
Fred Ward / Shaun Dobson Tel: +44 (0)20 7003 3000.
This information is provided by RNS
The company news service from the London Stock Exchange